Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chron

Konference: 2008 50th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: Chronic Lymphocytic Leukemia - Therapy, Excluding Transplantation

Číslo abstraktu: 325

Autoři: Prof. MD Michael Hallek; Guenter Fingerle-Rowson; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; prof. MUDr. Jiří Mayer, CSc.; Hensel Manfred; Hopfinger Georg; MD Georg Hess; von Gruenhagen Ulrich; Manuela A. Bergmann; MBBS John V. Catalano, FRACP FRCPA; Pier Luigi Zinzani; MD Federico Caligaris Cappio; Prof. John Francis Seymour, MD, PhD, MBBS, FRACP

Datum přednesení příspěvku: 6. 12. 2008